Tempest Therapeutics
Price & Volume
Stats
See moreOpen | $0.47 |
Previous Close | $0.46 |
Day Range | $0.46-$0.47 |
52W Range | $0.46-$10.32 |
Market Cap | $9.4M |
Shares Short | 312,948 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.93 |
News
See moreYahoo Finance • 6 months ago
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance • 6 months ago
Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting
Yahoo Finance • 8 months ago
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
About
CEO | Dr. Matthew Angel Ph.D. |
CFO | Ms. Stephanie Horn-Warnock |
Address | 2000 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |